Drug Topics

JANUARY 4, 2023

The researchers reported that there was no significant difference in the age-related macular degeneration prevalence among the 3 study groups.

503

503

Pharmacy Times

JANUARY 4, 2023

The FDA granted fidanacogene elaparvovec breakthrough, regenerative medicines advance therapy, and orphan drug designations.

FDA 152

FDA 152

Drug Topics

JANUARY 4, 2023

Reports of localized supply issues with Tamiflu have left some providers wondering how to best prioritize who gets the antiviral during a rough flu season.

469

469

STAT

JANUARY 4, 2023

Continuing economic uncertainty and the threat of a recession are casting a pall over health tech in 2023 — a dramatic shift for an industry that enjoyed abundant funding in the pandemic’s early stages. Last quarter’s string of layoffs at companies like Ro, Noom and ThirtyMadison portend tight budgets and conservative contracts this year, with employers unsure about which digital offerings actually drive down health care costs for workers.

FDA 145

FDA 145

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

JANUARY 4, 2023

Researchers speculate that the disparities among those with private insurance coverage may reflect differences in overcoming hurdles to access, such as prior authorization.

Insurance Coverage 247

Insurance Coverage Insurance 247

Pharmacy Times

JANUARY 4, 2023

The benefits of physical activity may be greater for children and adolescents with clinical depression or depressive symptoms, who may develop anxiety and other disorders in adulthood.

138

138

Pharmacy Times

JANUARY 4, 2023

A study showed that the risk of developing venous thromboembolism is worse for perimenopausal women with diabetes.

132

132

Fierce Pharma

JANUARY 4, 2023

Pfizer, GSK, AbbVie and many more celebrate New Year with price hikes: report. esagonowsky. Wed, 01/04/2023 - 10:21.

112

112

Pharmacy Times

JANUARY 4, 2023

Pharmacists play a vital role in administering these and educating patients about COVID-19, influenza, pneumococcal, and Tdap vaccinations.

Vaccines 131

Vaccines 131

Drug Store News

JANUARY 4, 2023

Nacho Vibes contains 2 g of protein and 3 g of fiber per 1-oz. serving, the company said.

106

106

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

JANUARY 4, 2023

Mentorship is a long-term and formative process and interaction that extends beyond initial discussions regarding the mentee's career path.

131

131

European Pharmaceutical Review

JANUARY 4, 2023

EVOQ Therapeutics Inc has agreed to license its NanoDisc technology for rheumatoid arthritis (RA) and lupus to Gilead Sciences, Inc, enabling EVOQ to potentially receive up $658.5 million. The companies will collaborate to advance preclinical development and Gilead will be responsible for clinical development and commercialisation. “Despite key advances over the past two decades, there remains significant unmet need for people living with inflammatory and autoimmune diseases,” stated Dr Flavius

Immunization 105

Immunization 105

Pharmacy Times

JANUARY 4, 2023

Children who experienced COVID-19-induced multisystem inflammatory syndrome did not experience severe adverse reactions following COVID-19 vaccination.

Adverse Reactions 123

Adverse Reactions Vaccines 123

PharmExec

JANUARY 4, 2023

Baker spoke on topics ranging from pricing, access, the war for talent, and other key areas that are impacting pharma companies.

105

105

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

JANUARY 4, 2023

Greater prevalence of hand eczema among health care professionals working in COVID-19 units linked to increased hand sanitation habits.

115

115

Fierce Pharma

JANUARY 4, 2023

Moderna makes its first-ever acquisition, buying Japanese DNA manufacturer OriCiro for $85M. mbayer. Wed, 01/04/2023 - 06:37.

104

104

STAT

JANUARY 4, 2023

SACRAMENTO, Calif. (AP) — About 600 people alive today can’t have children because California’s government sterilized them either against their will or without their knowledge, and now the state is trying to find them so it can pay them at least $15,000 each in reparations. But after a year of searching, the state has approved just 51 people for payments out of 310 applications.

103

103

The Guardian - Pharmaceutical Industry

JANUARY 4, 2023

Pharmacy leaders cite ministers’ ‘lack of planning’ amid problems obtaining common products A shortage of cough and cold medicines in the UK is a result of ministers’ “lack of planning”, according to pharmacy leaders. Rishi Sunak’s Conservatives were accused of “being in denial” as supply chain problems worsen, with pharmacists reporting shortages of once-common cold and flu medicines.

98

98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

STAT

JANUARY 4, 2023

For the first two years of the Covid-19 pandemic, people working in the infectious diseases and global health spheres were largely focused on the new disease. In 2022, however, gears shifted. Covid didn’t go away, but diseases like flu that had been held in abeyance by the new virus and the measures we used to slow its spread — well, they’re baaack.

Hospitals 98

Hospitals 98

pharmaphorum

JANUARY 4, 2023

More than 30 years after it was first formed, Geron is on the cusp of bringing its first product to market, after imetelstat hit the mark in a phase 3 trial in patients with myelodysplastic syndromes (MDS). The Foster City, California-based biotech said today that its IMerge trial of imetelstat – vying to become the first telomerase inhibitor to reach the market – hit its objectives in patients with lower risk MDS, a rare group of bone marrow cancers.

98

98

Drug Store News

JANUARY 4, 2023

H-E-B, Walmart, Kroger, Publix and ShopRite earned the top five spots in the most trusted private label products category.

Labelling 98

Labelling 98

DiversifyRx

JANUARY 4, 2023

Pharmacy marketing is one of our favorite topics at DiversifyRx. Here are our top blogs to help you improve your pharmacy’s marketing. Last week we shared our Top 2022 Blog Resources To Optimize your PBM Revenue , which covers our third Pharmacy Profit Pillar PBM Optimization. This week we will dive into the most popular blogs from 2022 that focus on independent pharmacy marketing, our fourth Pharmacy Profit Pillar.

Independent Pharmacies 98

Independent Pharmacies 98

Drug Store News

JANUARY 4, 2023

The Consolidated Appropriations Act will increase competition from generic and biosimilar medicines and enhance patient access to lower cost prescription drugs.

98

98

Fierce Healthcare

JANUARY 4, 2023

Increasing financial compensation could drive more diverse clinical trial participation, study says. fdiamond. Wed, 01/04/2023 - 15:15.

98

98

Drug Store News

JANUARY 4, 2023

As of Jan. 1, the minimum wage has gone up in 23 states and Washington, D.C. The dollar amount varies and ranges between $9.95 and $15.74.

98

98

Hospital Pharmacy Europe

JANUARY 4, 2023

A comparative analysis with common viral infections suggests that many recognised post COVID-19 condition symptoms are not unique to the virus. According to the findings of an analysis by US researchers, only some of the post COVID-19 condition symptoms can be uniquely attributed to infection with the virus when compared to the post-infection symptoms induced by other, common viral infections.

Cerner 98

Cerner Hospitals 98

pharmaphorum

JANUARY 4, 2023

The proposed EHDS Regulation 1 ( Proposal ), introduced in May 2022 by the European Commission (EC), aims to reform the “situation of fragmentation” that depicts the existing approach to health data access across Europe 2 through the establishment of a centralised data system. The intention is to streamline the process for patients wishing to access their medical records via electronic health record systems (“EHR systems”) and to facilitate the ability for researchers, innovators, and policy mak

Medical Records 98

Medical Records Insurance Hospitals 98

Fierce Healthcare

JANUARY 4, 2023

November's hospital margins up 12% monthly thanks to cooling expenses. dmuoio. Wed, 01/04/2023 - 16:21.

Hospitals 98

Hospitals 98

Drug Store News

JANUARY 4, 2023

As part of this year’s summit, Hy-Vee will work to identify suppliers with diverse backgrounds and is encouraging minority-owned and women-owned businesses to apply.

98

98

STAT

JANUARY 4, 2023

An experimental inflammatory bowel disease medicine that serves as the basis for a partnership between Roivant Sciences and Pfizer met high expectations for a Phase 2 clinical trial data released Wednesday. In a clinical study of 245 volunteers, the drug, called RVT-3101, helped 32% of trial participants with ulcerative colitis go into remission, compared to 12% in the placebo group.

98

98

Pharmaceutical Technology

JANUARY 4, 2023

The China National Medical Products Administration’s (NMPA) Center for Drug Evaluation (CDE) has granted clearance for Transcenta’s investigational new drug (IND) application for its TST003 to treat solid tumours. TST003 is a first-in-class Gremlin1 targeting humanised monoclonal antibody. It has demonstrated better single-agent activities in patient-derived xenograft tumour models of many difficult-to-treat solid tumours, including microsatellite stable colorectal cancer and castration-resistan

FDA 97

FDA 97

NF2 BioSolutions

JANUARY 4, 2023

We are doing 2 fundraising challenges throughout the year this year and you can partake in any whenever you like, get everyone involved from mums, dads, kids, grandparents, aunts, uncles, neighbours, friends and work colleagues. HAVE FUN AND RAISE FUNDS FOR NF2 RESEARCH! CAKE BAKE & COFFEE. Hold a cake sale and/or Coffee morning for this fundraiser.

Labelling 96

Labelling 96

The Checkup by Singlecare

JANUARY 4, 2023

A blood test for diabetes measures the amount of glucose or sugar in a person’s blood. Diabetes is a condition in which the body has trouble converting sugar from food into energy. It can be caused when there isn’t enough insulin or the insulin in the body is not working well enough to process sugar. This can lead to high blood sugar levels in the bloodstream, causing symptoms like increased thirst and frequent urination, among other complications, as the disease progresses. .

96

96